Fund Holdings — SUPERSTRING CAPITAL MANAGEMENT LP

Total Portfolio Value:
$199.52M
Total Bought:
$74.36M
Total Sold:
$33.80M
Net Transaction:
+$40.56M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Cogent Biosciences, Inc.(COGT)343,284597,408+254,124$13.29M$19.13M9.59%+$5.84M
Axsome Therapeutics, Inc.(AXSM)53,916102,485+48,569$13.20M$18.90M9.47%+$5.70M
Trevi Therapeutics, Inc.(TRVI)524,224984,892+460,668$9.78M$14.10M7.07%+$4.33M
Genmab A/SADS(GMAB)430,600365,662-64,938$11.83M$13.04M6.54%+$1.22M
Climb Bio Inc521,082918,231+397,149$6.79M$10.53M5.28%+$3.74M
Zai Lab LimitedADR(ZLAB)155,813362,671+206,858$2.96M$9.55M4.79%+$6.59M
Adlai Nortye Group LtdADS552,501588,418+35,917$6.35M$9.41M4.72%+$3.06M
Revolution Medicines, Inc.(RVMD)51,05341,784-9,269$9.56M$8.58M4.30%-$984.6K
Celldex Therapeutics, Inc.(CLDX)287,583242,493-45,090$10.70M$7.86M3.94%-$2.84M
Immunovant, Inc.(IMVT)208,368222,121+13,753$8.03M$7.50M3.76%-$525.2K
UroGen Pharma Ltd.(URGN)191,313184,392-6,921$7.04M$7.49M3.75%+$451.5K
United Therapeutics Corporation(UTHR)7,17213,321+6,149$3.89M$7.22M3.62%+$3.33M
Legend Biotech CorporationADS(LEGN)0357,359+357,359$0$7.11M3.56%+$7.11M
Definium Therapeutics, Inc.(DFTX)188,282176,561-11,721$8.86M$6.72M3.37%-$2.14M
Roivant Sciences Ltd.SHS(ROIV)25,623178,842+153,219$906.8K$6.54M3.28%+$5.63M
Vir Biotechnology, Inc.(VIR)853,685578,696-274,989$8.70M$6.47M3.24%-$2.23M
Ionis Pharmaceuticals, Inc.(IONS)0132,339+132,339$0$5.91M2.96%+$5.91M
Savara Inc.(SVRA)977,4601,017,817+40,357$6.02M$5.25M2.63%-$769.2K
Sagimet Biosciences IncCOM SER A0423,006+423,006$0$4.18M2.09%+$4.18M
ABIVAX Société AnonymeADS(ABVX)030,020+30,020$0$2.97M1.49%+$2.97M
Ginkgo Bioworks Holdings IncCL A0222,553+222,553$0$2.86M1.43%+$2.86M
Spyre Therapeutics, Inc.(SYRE)030,022+30,022$0$2.67M1.34%+$2.67M
Bright Minds Biosciences Inc30,45648,045+17,589$2.14M$2.39M1.20%+$255.6K
Kiniksa Pharmaceuticals International, plcCL A(KNSA)18,86731,684+12,817$1.21M$2.36M1.18%+$1.16M
Taysha Gene Therapies, Inc.(TSHA)0413,373+413,373$0$2.01M1.01%+$2.01M
Latigo Biotherapeutics Inc088,178+88,178$0$1.47M0.74%+$1.47M
Oruka Therapeutics, Inc.(ORKA)015,446+15,446$0$1.29M0.64%+$1.29M
Maplight Therapeutics Inc125,432118,304-7,128$4.50M$1.21M0.60%-$3.29M
Madrigal Pharmaceuticals, Inc.(MDGL)02,099+2,099$0$1.06M0.53%+$1.06M
Cabaletta Bio Inc1,278,652517,412-761,240$3.48M$993.4K0.50%-$2.48M
Xenon Pharmaceuticals Inc.(XENE)026,496+26,496$0$985.4K0.49%+$985.4K
Tonix Pharmaceuticals Hldg C63,64874,688+11,040$812.1K$727.5K0.36%-$84.7K
Boundless Bio Inc55,356206,242+150,886$138.4K$517.7K0.26%+$379.3K
GRAIL, Inc.(GRAL)03,238+3,238$0$453.7K0.23%+$453.7K
Biomea Fusion Inc250,000225,872-24,128$85.3K$44.6K0.02%-$40.7K
Aclaris Therapeutics, Inc.(ACRS)257,6750-257,675$1.36M$0—-$1.36M
BeOne Medicines AGADS(ONC)12,2730-12,273$3.50M$0—-$3.50M
Cybin D/B/A Helus Pharma(HELP)204,4240-204,424$1.35M$0—-$1.35M
Faeth Therapeutics, Inc.(FTH)14,1750-14,175$354.4K$0—-$354.4K
ORIC Pharmaceuticals, Inc.(ORIC)406,0770-406,077$4.40M$0—-$4.40M
Protara Therapeutics, Inc.(TARA)121,4570-121,457$464.0K$0—-$464.0K
Sionna Therapeutics, Inc.(SION)63,1560-63,156$2.78M$0—-$2.78M
Vaxcyte, Inc.(PCVX)66,7930-66,793$3.88M$0—-$3.88M
Yarrow Bioscience Inc(YARW)61,2690-61,269$39.9K$0—-$39.9K
Page 1 of 1
SUPERSTRING CAPITAL MANAGEMENT LP — 13F Holdings — Q3 2026 | TickerTrail